The Food and Drugs Authority Ghana (FDA) has issued a warning over the circulation of counterfeit VISITECT CD4 Advanced Disease test kits, cautioning that their use could pose serious health risks.
According to the regulator, the falsified kits may produce inaccurate results, potentially leading to misdiagnosis, delayed treatment, and severe health complications—particularly for vulnerable patients who require timely medical intervention.
The FDA revealed that the counterfeit products bear lot number 0001586 and incorrectly list Omega Diagnostics Limited as the manufacturer.
In contrast, the genuine VISITECT CD4 Advanced Disease test kits are produced by AccuBio Limited, also based in the United Kingdom. Authentic products carry lot number 0002172 and come with distinct specifications that differentiate them from the fake versions.
The FDA further noted discrepancies in manufacturing and expiry dates between the genuine and counterfeit kits.
While the original kits were manufactured in July 2025 and are set to expire in November 2026, the falsified versions indicate a manufacturing date of August 2024 and an expiry date of January 2027.
The Authority is urging healthcare providers and the public to remain vigilant and ensure that only verified medical products are used in clinical settings to avoid potential harm.
 has issued a warning over the circulation of counterfeit VISITECT CD4 Advanced Disease test kits, cautioning that their use could pose serious health risks.){kind=link}